Galectin Therapeutics Inc (GALT) bonds
GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.91−0.11 (-3.64%)
Close on Nov 17, 2026Market cap $293.47MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Galectin Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Galectin Therapeutics's 10-Q for the period ended Jun 30, 2026
Galectin Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Expires |
|---|---|---|
| December2025 Supplemental LOC | $10.00M | Jun 30, 2027 |
| July2025 Supplemental LOC | $10.00M | Jun 30, 2027 |
| Line Of Credit | $60.00M | Jun 30, 2027 |
| March2025 Supplemental LOC | $5.00M | Jun 30, 2027 |
| November2024 Supplemental LOC | $6.00M | Jun 30, 2027 |
| Supplemental LOC2024 | $10.00M | Jun 30, 2027 |
| July2025 Supplemental LOC One | $10.00M | – |
| Original LOC December192022 | $10.00M | – |
| Original LOC December292023 | $10.00M | – |
| Original LOC June282024 | $10.00M | – |
| Original LOC June302023 | $10.00M | – |
| Original LOC March292024 | $10.00M | – |
| Original LOC March312023 | $10.00M | – |
See a number that looks wrong?